Cargando…

Interactive dose shaping part 2: proof of concept study for six prostate patients

Recently we introduced interactive dose shaping (IDS) as a new IMRT planning strategy. This planning concept is based on a hierarchical sequence of local dose modification and recovery operations. The purpose of this work is to provide a feasibility study for the IDS planning strategy based on a sma...

Descripción completa

Detalles Bibliográficos
Autores principales: Ph Kamerling, Cornelis, Ziegenhein, Peter, Sterzing, Florian, Oelfke, Uwe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOP Publishing 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390954/
https://www.ncbi.nlm.nih.gov/pubmed/26948274
http://dx.doi.org/10.1088/0031-9155/61/6/2471
_version_ 1782521554244993024
author Ph Kamerling, Cornelis
Ziegenhein, Peter
Sterzing, Florian
Oelfke, Uwe
author_facet Ph Kamerling, Cornelis
Ziegenhein, Peter
Sterzing, Florian
Oelfke, Uwe
author_sort Ph Kamerling, Cornelis
collection PubMed
description Recently we introduced interactive dose shaping (IDS) as a new IMRT planning strategy. This planning concept is based on a hierarchical sequence of local dose modification and recovery operations. The purpose of this work is to provide a feasibility study for the IDS planning strategy based on a small set of six prostate patients. The IDS planning paradigm aims to perform interactive local dose adaptations of an IMRT plan without compromising already established valuable dose features in real-time. Various IDS tools were developed in our in-house treatment planning software Dynaplan and were utilized to create IMRT treatment plans for six patients with an adeno-carcinoma of the prostate. The sequenced IDS treatment plans were compared to conventionally optimized clinically approved plans (9 beams, co-planar). For each patient, several IDS plans were created, with different trade-offs between organ sparing and target coverage. The reference dose distributions were imported into Dynaplan. For each patient, the IDS treatment plan with a similar or better trade-off between target coverage and OAR sparing was selected for plan evaluation, guided by a physician. For this initial study we were able to generate treatment plans for prostate geometries in 15–45 min. Individual local dose adaptations could be performed in less than one second. The average differences compared to the reference plans were for the mean dose: 0.0 Gy (boost) and 1.2 Gy (PTV), for [Formula: see text] Gy and for [Formula: see text] Gy (both target volumes). The dose-volume quality indicators were well below the Quantec constraints. However, we also observed limitations of our currently implemented approach. Most prominent was an increase of the non-tumor integral dose by 16.4% on average, demonstrating that further developments of our planning strategy are required.
format Online
Article
Text
id pubmed-5390954
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher IOP Publishing
record_format MEDLINE/PubMed
spelling pubmed-53909542017-04-27 Interactive dose shaping part 2: proof of concept study for six prostate patients Ph Kamerling, Cornelis Ziegenhein, Peter Sterzing, Florian Oelfke, Uwe Phys Med Biol Paper Recently we introduced interactive dose shaping (IDS) as a new IMRT planning strategy. This planning concept is based on a hierarchical sequence of local dose modification and recovery operations. The purpose of this work is to provide a feasibility study for the IDS planning strategy based on a small set of six prostate patients. The IDS planning paradigm aims to perform interactive local dose adaptations of an IMRT plan without compromising already established valuable dose features in real-time. Various IDS tools were developed in our in-house treatment planning software Dynaplan and were utilized to create IMRT treatment plans for six patients with an adeno-carcinoma of the prostate. The sequenced IDS treatment plans were compared to conventionally optimized clinically approved plans (9 beams, co-planar). For each patient, several IDS plans were created, with different trade-offs between organ sparing and target coverage. The reference dose distributions were imported into Dynaplan. For each patient, the IDS treatment plan with a similar or better trade-off between target coverage and OAR sparing was selected for plan evaluation, guided by a physician. For this initial study we were able to generate treatment plans for prostate geometries in 15–45 min. Individual local dose adaptations could be performed in less than one second. The average differences compared to the reference plans were for the mean dose: 0.0 Gy (boost) and 1.2 Gy (PTV), for [Formula: see text] Gy and for [Formula: see text] Gy (both target volumes). The dose-volume quality indicators were well below the Quantec constraints. However, we also observed limitations of our currently implemented approach. Most prominent was an increase of the non-tumor integral dose by 16.4% on average, demonstrating that further developments of our planning strategy are required. IOP Publishing 2016-03-21 2016-03-07 /pmc/articles/PMC5390954/ /pubmed/26948274 http://dx.doi.org/10.1088/0031-9155/61/6/2471 Text en © 2016 Institute of Physics and Engineering in Medicine http://creativecommons.org/licenses/by/3.0/ Original content from this work may be used under the terms of the Creative Commons Attribution 3.0 licence (http://creativecommons.org/licenses/by/3.0) . Any further distribution of this work must maintain attribution to the author(s) and the title of the work, journal citation and DOI.
spellingShingle Paper
Ph Kamerling, Cornelis
Ziegenhein, Peter
Sterzing, Florian
Oelfke, Uwe
Interactive dose shaping part 2: proof of concept study for six prostate patients
title Interactive dose shaping part 2: proof of concept study for six prostate patients
title_full Interactive dose shaping part 2: proof of concept study for six prostate patients
title_fullStr Interactive dose shaping part 2: proof of concept study for six prostate patients
title_full_unstemmed Interactive dose shaping part 2: proof of concept study for six prostate patients
title_short Interactive dose shaping part 2: proof of concept study for six prostate patients
title_sort interactive dose shaping part 2: proof of concept study for six prostate patients
topic Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390954/
https://www.ncbi.nlm.nih.gov/pubmed/26948274
http://dx.doi.org/10.1088/0031-9155/61/6/2471
work_keys_str_mv AT phkamerlingcornelis interactivedoseshapingpart2proofofconceptstudyforsixprostatepatients
AT ziegenheinpeter interactivedoseshapingpart2proofofconceptstudyforsixprostatepatients
AT sterzingflorian interactivedoseshapingpart2proofofconceptstudyforsixprostatepatients
AT oelfkeuwe interactivedoseshapingpart2proofofconceptstudyforsixprostatepatients